Nine quinoline-degrading bacterial strains were tested for their ability to hydroxylate pyrimidine. All strains converted pyrimidine to uracil via pyrimidine-4-one in a cometabolic process. Quinoline 2-oxidoreductases (QuinORs) were the catalysts of fortuitous pyrimidine hydroxylation. Whereas in most strains the activity of the QuinOR towards pyrimidine was very low compared to its activity towards quinoline, QuinOR in crude extracts from Comamonas testosteroni 63 showed a specific activity of 64 (mU mg protein)
Introduction
Molybdenum-containing enzymes involved in the bacterial degradation of N-heteroaromatic compounds catalyze regiospeci¢c hydroxylation reactions [1, 2] . Since the regiospeci¢c functionalization of Nheteroaromatic compounds may be di¤cult to achieve by chemical methods, the preparation of hydroxy-substituted N-heterocycles by microbial hydroxylation may be advantageous. Actually, bioconversion processes can be used for the generation of carbostyril and 6-hydroxycarbostyril from quinoline [3] , 3-cyano-6-hydroxypyridine from 3-cyanopyridine [4] , for the large-scale synthesis of 6-hydroxynicotinate from nicotinate [5^7], and 6-hydroxypicolinate from 2-cyanopyridine or picolinate [8] . As a ¢rst step towards the development of a bioconversion method to produce 2-hydroxynicotinate, a bacterium which regiospeci¢cally hydroxylates nicotinate at position C-2 has been isolated [9] .
Quinoline 2-oxidoreductases (QuinORs), which have been puri¢ed from several aerobic bacteria [10^13] , are molybdenum-containing hydroxylases catalyzing the hydroxylation of quinoline and some distinct methyl-, chloro-, and hydroxy-substituted quinoline derivatives [10^12] . QuinOR from Pseudo-monas putida 86 has also been shown to hydroxylate position C-2 of the benzodiazines quinazoline and quinoxaline [14] . QuinORs from di¡erent bacterial strains di¡er in their substrate speci¢cities and in their relative activities towards the bicyclic N-heteroaromatic substrates tested so far [10^12] . Since the QuinORs from Comamonas testosteroni 63, P. putida 86, and Rhodococcus sp. B1 show signi¢cant stability and constitute about 9% [12] , 2^3% [10, 13] , and 2.7% [11] of cellular protein in the induced biomass, respectively, bacterial strains expressing QuinORs might be useful for the co-metabolic hydroxylation of N-heteroaromatic compounds which are not utilized for growth but which are accepted as substrates by the molybdenum-containing hydroxylase. In order to assess the possibility of introducing hydroxyl substituents into monocyclic N-heteroaromatic compounds, pyrimidine was chosen as a model, and nine di¡erent quinoline-degrading strains were tested for their ability to regiospeci¢cally hydroxylate pyrimidine. Derivatives of hydroxy-substituted pyrimidines constitute an important class of pharmaceuticals (mainly antiviral and antineoplastic agents [15, 16] ) and agrochemicals [16, 17] .
Materials and methods

Materials
Quinoline (v 97%), pyrimidine (v 98%), pyrimidine-2-one (V97%), and pyrimidine-4,6-dione (v 97%) were purchased from Fluka. Pyrimidine-4-one and uracil were a gift from Lonza AG, Visp, Switzerland. Serdolit PADIII polymeric adsorbent resin (0.3^1.0 mm) was from Boehringer Ingelheim Bioproducts, and Amberlite XAD-2 polymeric adsorbent was obtained from Supelco (Sigma-Aldrich).
Bacterial strains, growth conditions, and resting cell conditions
The bacterial strains Rhodococcus sp. B1, P. putida 86, P. putida 89, P. putida 82, Pseudomonas sp. Ru « 2 (DSM 12196), P. £uorescens 3, C. testosteroni R, and C. testosteroni 17 (DSM 12195) have been described by Schwarz et al. [18] . Except for Rhodococcus sp. B1, these strains were grown in mineral salts medium composed of ( [19] , except that quinoline instead of 3-methylquinoline was used as carbon source. All growth media contained 3 mM quinoline as sole source of carbon and energy. To test pyrimidine utilization by the bacterial strains, 2 mM pyrimidine instead of quinoline was added as sole carbon source, turbidity of the cell suspensions (OD 600nm ) was determined for up to 3 weeks to monitor growth, and UV/Vis spectra of culture supernatants were measured to indicate pyrimidine consumption. All cultures were incubated on an orbital shaker (120 rpm) at 30³C.
For resting cell experiments, cells of the late exponential growth phase were harvested by centrifugation and resuspended in 100 mM sodium phosphate bu¡er (pH 7.2). Unless noted otherwise, OD 600nm of the resting cell suspensions was adjusted to 12, pyrimidine (2 mM) was added, and the suspensions were incubated at 30³C. At appropriate time intervals, aliquots of the cell suspensions were centrifuged, and the supernatants were frozen until analyzed. Biomass harvested after the resting incubation was stored at 380³C. For the estimation of protein concentrations of cell suspensions, aliquots were mixed with 1/10 volume of 4 M NaOH, boiled for 10 min, and centrifuged brie£y. Protein concentrations in these supernatants were estimated by the Lowry method using bovine serum albumin as standard [20] .
High pressure liquid chromatography (HPLC)
Reversed-phase HPLC was carried out on a Hypersil ODS column (3 Wm, 250U4 mm) at a £ow rate of 0.6 ml min 31 . 66 mM So « rensen's phosphate buffer, pH 5.0 (A), and methanol/water (35/65, v/v) (B) were used as eluents (A from 0 to 9 min; A/B, 50/50 (v/v) from 9.5 to 20 min). Hydroxypyrimidines were separated with eluent A, pyrimidine eluted with A/B, 50/50 (v/v/v). Eluted compounds were detected at 220 nm and 243 nm. Hydroxypyrimidines were identi¢ed by co-chromatography with authentic references and by their UV absorption spectra (UV/Vis photodiode array detector UVD340, Gynkosoft). The retention times of pyrimidine, uracil, pyrimidine-4-one, pyrimidine-2-one, and pyrimidine-4,6-dione were 16 min, 7.1 min, 7.6 min, 6.4 min, and 4.3 min, respectively. Concentrations of pyrimidine-4-one and uracil were determined by HPLC after calibration with reference compounds as external standards.
Puri¢cation of uracil from resting cell suspensions
Resting cells of C. testosteroni 63 after 29 h of incubation with 15 mM pyrimidine were centrifuged. An aliquot (3 ml) of the supernatant was applied to a 0.6U20 cm Serdolit PADIII column that had been equilibrated in deionized water. After washing the column with 60 ml of water to remove inorganic salts, adsorbed uracil was eluted with methanol. Fractions were assayed by HPLC.
Preparation of crude extracts, and enzyme assays
Bacterial cells, suspended in an equal volume of 100 mM Tris-HCl bu¡er (pH 7.5), were disrupted by ultrasonic treatment (Branson soni¢er 250, micro tip, 15 min, 30% duty cycle), and centrifuged for 45 min at 14 000Ug. Activity of QuinORs was determined photometrically by measuring substrate-dependent reduction of the arti¢cial electron acceptor p-iodonitro-tetrazolium violet (INT) to its red formazan [10] . Quinoline (1.7 mM) or pyrimidine (1.5 and 3 mM) were used as substrate. One unit of enzyme activity was de¢ned as the amount of enzyme that produced 1 Wmol of formazan per minute at 25³C. Protein concentrations in crude extract were determined according to Lowry et al. [20] .
Polyacrylamide gel electrophoresis (PAGE)
Non-denaturing polyacrylamide gels were prepared as described by Hames [21] , using 10% resolving and 4% stacking gels in the high pH system. Proteins were stained with Coomassie Blue R250 (0.1% (w/v) in trichloroacetic acid/water, 50/50, w/ v), and destained in methanol/acetic acid/water (30/ 10/60, v/v/v). For activity staining of QuinORs, gels were immersed in standard assay solution [10] containing quinoline or pyrimidine as substrate.
Results and discussion
Conversion of pyrimidine to uracil by resting cells of quinoline-grown bacterial strains
In mineral salts medium containing 2 mM pyrimi- dine, neither growth of bacteria nor pyrimidine conversion was observed, indicating that none of the nine quinoline-degrading strains utilized pyrimidine as sole source of carbon and energy. The results shown in Fig. 1 suggest that resting cells of all strains tested converted pyrimidine to uracil via pyrimidine-4-one, as revealed by HPLC analysis. Pyrimidine-2-one and pyrimidine-4,6-dione were not detected in the resting cell supernatants. Due to the incomplete separation of pyrimidine from (an) unidenti¢ed compound(s), the HPLC protocol did not allow determination of pyrimidine concentrations. However, analysis of samples taken from the resting cell suspensions after more than 30 h of incubation indicated that in all suspensions pyrimidine was consumed completely. Resting cells of most strains formed substoichiometric amounts of uracil, which was degraded further via unknown metabolites (Fig. 1A^G) . Rhodococcus sp. B1 slowly accumulated uracil from pyrimidine (Fig. 1H) . C. testosteroni 63 was the only strain that rapidly converted pyrimidine almost stoichiometrically to uracil (Fig. 1I, Fig. 2 ). 
Identi¢cation of the enzyme catalyzing pyrimidine hydroxylation
To assess whether pyrimidine hydroxylation by the quinoline-degrading strains was due to a fortuitous activity of QuinOR, crude extracts from quinolinegrown cells and from resting cells after incubation with pyrimidine were subjected to non-denaturing PAGE, and gel slices were immersed in bu¡er containing INT, or INT in bu¡er plus quinoline, or INT in bu¡er plus pyrimidine. When the electrophoretically separated proteins of the crude extracts of eight of the strains were incubated with INT plus quinoline or with INT plus pyrimidine, in each crude extract a single protein band turned red due to formazan formation, both in extracts from quinolinegrown cells and in extracts from cells incubated with pyrimidine. Fig. 3A shows the polyacrylamide gel of crude extracts from C. testosteroni 17 as a representative example. Crude extracts from Rhodococcus sp. B1, P. £uorescens 3, P. putida 82, P. putida 89, C. testosteroni R, P. putida 86, and Pseudomonas sp. Ru « 2 revealed a staining pattern that corresponded to the one shown in Fig. 3A . In each case, the relative mobility in the polyacrylamide gel of QuinOR, stained with INT plus quinoline, corresponded to the relative mobility of the protein stained with INT plus pyrimidine, irrespective of the growth or incubation conditions, suggesting that in each strain quinoline and pyrimidine are indeed converted by the same enzyme. (However, the QuinORs of di¡erent strains exhibited distinct mobilities in the polyacrylamide gels.) Apparently, none of the strains tested induced a speci¢c`pyrimidine hydroxylase'. In extracts of C. testosteroni 63 separated by PAGE, an additional protein was observed whose staining due to INT reduction was independent of the presence of any substrate (Fig. 3B) . Since the staining intensity of this protein in gel slices immersed in INT solution and immersed in INT plus pyrimidine was similar (lanes 2 and 3 in Fig. 3B ), this protein represents a substrate-independent INT reductase activity' rather than a pyrimidine hydroxylase. Thus, pyrimidine hydroxylation by all strains is merely due to the fortuitous activity of the QuinORs towards pyrimidine.
Activity and substrate speci¢city of the QuinORs catalyzing pyrimidine hydroxylation
Bioconversion processes using resting cells, which are devoid of any external source of energy, require that the catalytic enzyme is su¤ciently stable during the resting cell incubation. Signi¢cant losses of Quin-OR activity (towards quinoline as substrate) were observed in crude extracts of eight strains after incubation of the resting cells in sodium phosphate bu¡er with 2 mM pyrimidine for 2 days (Table 1) . In contrast, the activity of the QuinOR in crude extracts from Rhodococcus sp. B1 did not decrease signi¢cantly during the resting cells incubation (177 mU (mg protein) 31 in crude extract from quinolinegrown cells versus 173 mU (mg protein) 31 in crude extract from cells after 2 days of incubation under resting conditions). Unfortunately, the Rhodococcus enzyme was only weakly active towards the fortuitous substrate pyrimidine, as also indicated in Table  1 . In eight of the strains tested, the relative activities of the QuinORs with pyrimidine as substrate, determined in crude extracts from quinoline-grown cells, were very low, as compared to the activity towards quinoline (Table 1) . QuinOR in crude extract from C. testosteroni 63, however, showed signi¢cant activity with pyrimidine as substrate (Table 1) . Thus, resting cells of C. testosteroni 63 are able to rapidly convert pyrimidine (2 mM) to uracil, which accumulates within a few hours (Fig. 1I) . When the resting cells were incubated with higher pyrimidine concentrations (up to 20 mM), the hydroxylation reaction occurred at the same rate (Fig. 2) , indicating that neither pyrimidine nor uracil a¡ects the activity of QuinOR (in the sense of substrate or product inhibition, respectively).
QuinOR from C. testosteroni 63 is assumed to belong to the`xanthine oxidase family' of molybdenum-containing hydroxylases [2, 12] . Xanthine oxidases/dehydrogenases as well as some other molybdenum-containing hydroxylases active towards Nheteroaromatic compounds are known to exhibit broad substrate speci¢cities [1, 22] . Xanthine oxidase from bovine milk oxidizes pyrimidine, pyrimidine-4-one, and uracil with rates of 6 3%, 130%, and 6 3%, respectively, relative to the rates observed with purine as substrate [22] . Thus, substitution at position C-4 of pyrimidine enhanced the rate of oxidation by xanthine oxidase. In contrast, QuinOR from C. testosteroni 63 was more active towards pyrimidine than towards pyrimidine-4-one, as shown in Table 2 .
Whereas QuinOR activity in crude extracts from quinoline-grown cells of strain 63 was 237 mU (mg protein)
31 , extracts from succinate-grown cells contained less than 10 mU of QuinOR per mg of protein ( Table 2 ), suggesting that QuinOR synthesis is induced by its substrate.
Preparation of uracil from resting cell suspensions of C. testosteroni 63
Uracil was prepared from the supernatant of C. testosteroni 63 resting cells by means of a polymeric adsorbent resin (Serdolit PADIII). Another adsorbent tested (Amberlite XAD-2) did not bind the uracil, presumably due to the marked hydrophilicity of uracil. The PADIII column allowed separation of the organic compound from the inorganic salts of the bu¡er used to suspend the cells. No educt was left in the cell suspension, which facilitated the isolation of the product. From resting cells incubated with 15 mM pyrimidine which had produced 13.5 mM uracil, uracil was prepared from the cell suspension with a yield of 98^99%. 
Conclusions
Although all quinoline-degrading bacteria tested due to the activity of their QuinORs catalyzed the fortuitous hydroxylation of the monocyclic N-heteroaromatic compound pyrimidine to uracil, the results of the bioconversion experiments di¡ered considerably. For the applicability of whole cells as biocatalysts, both the strict speci¢city of the catalyzed reaction and the persistence of the product are essential [23] . In some bioconversion processes, product degradation is minimized or even prevented by optimization of the fermentation procedure. For example, high concentrations of nicotinate, which strongly inhibit the second enzyme of the nicotinate degradation pathway, are applied during the industrial production of 6-hydroxy-nicotinate from nicotinate by Achromobacter xylosoxidans strain LK1 [7] . However, bacterial strains with the ability to co-metabolically transform an educt to a metabolic deadend product which accumulates in the cell suspension should be advantageous for the development of bioconversion processes.
